Promising diagnostic test for breast cancer brain metastasis never gets off the ground
NCT ID NCT03974204
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study was designed to see if analyzing tiny particles called exosomes in spinal fluid could help doctors diagnose leptomeningeal metastasis—a serious complication where breast cancer spreads to the membranes around the brain and spinal cord. Researchers planned to collect spinal fluid and blood samples from breast cancer patients with suspected spread. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Régional Universitaire de Lille
Lille, Hauts-de-France, 59000, France
-
Centre Oscar Lambret
Lille, Hauts-de-France, 59020, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?